更正：沈，J.；等人。T细胞中的生物衰老标志物p16与乳腺癌风险。2020年，，3122。
Correction: Shen, J.; et al. Biological Aging Marker p16 in T Cells and Breast Cancer Risk. 2020, , 3122.
作者信息
Shen Jie, Song Renduo, Fuemmeler Bernard F, McGuire Kandace P, Chow Wong-Ho, Zhao Hua
机构信息
Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Departments of Family Medicine and Population Health, School of Medicine, Virginia Commonwealth University, Richmond, VA 23284, USA.
出版信息
Cancers (Basel). 2021 Jan 17;13(2):329. doi: 10.3390/cancers13020329.
Abstract
The authors wish to make the following corrections to this paper [...].
摘要
作者希望对本文做出如下更正
[...]
相似文献
1
Correction: Shen, J.; et al. Biological Aging Marker p16 in T Cells and Breast Cancer Risk. 2020, , 3122.更正：沈，J.；等人。T细胞中的生物衰老标志物p16与乳腺癌风险。2020年，，3122。
Cancers (Basel). 2021 Jan 17;13(2):329. doi: 10.3390/cancers13020329.
2
Biological Aging Marker p16 in T Cells and Breast Cancer Risk.T细胞中的生物衰老标志物p16与乳腺癌风险
Cancers (Basel). 2020 Oct 26;12(11):3122. doi: 10.3390/cancers12113122.
3
Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.撤回声明：脊髓胶质细胞中的CXCL12/CXCR4趋化因子信号通过丝裂原活化蛋白激酶介导的神经炎症诱导骨癌大鼠疼痛超敏反应。
J Neurochem. 2017 May;141(3):473-474. doi: 10.1111/jnc.13949. Epub 2017 Mar 6.
4
A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.一项 1/2a 期研究，旨在测试 p16(INK4a) 肽疫苗在晚期人乳头瘤病毒相关癌症患者中的安全性和免疫原性。
Cancer. 2016 May 1;122(9):1425-33. doi: 10.1002/cncr.29925. Epub 2016 Mar 7.
5
Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.乳腺癌中衰老标志物p14(ARF)和p16(INK4a)表达增加与疾病复发风险增加及生存预后不良相关。
Histopathology. 2016 Sep;69(3):479-91. doi: 10.1111/his.12948. Epub 2016 Apr 28.
6
Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. 2021, , 1950.更正：麦卡特·里德等人。小叶型乳腺癌的基因组图谱。2021年，，1950。 （注：原文中“2021,,”表述似乎有误，不太明确准确意思）
Cancers (Basel). 2021 Aug 9;13(16):4010. doi: 10.3390/cancers13164010.
7
[Experimental study of relationship between effect of ginsenoside Rg1 to delay hematopoietic stem cell senescence and expression of p16(INK4a)].人参皂苷Rg1延缓造血干细胞衰老作用与p16(INK4a)表达关系的实验研究
Zhongguo Zhong Yao Za Zhi. 2011 Mar;36(5):608-13.
8
The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.p16(INK4a) 或 p19(ARF) 缺陷对细胞生长和肿瘤发生的差异影响。
Oncogene. 2004 Jan 15;23(2):379-85. doi: 10.1038/sj.onc.1207074.
9
Chemotherapy and Stem Cell Transplantation Increase p16 Expression, a Biomarker of T-cell Aging.化疗和干细胞移植会增加p16的表达，p16是T细胞衰老的生物标志物。
EBioMedicine. 2016 Sep;11:227-238. doi: 10.1016/j.ebiom.2016.08.029. Epub 2016 Aug 21.
10
Correction: Oh, J.Y., et al. Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells, 2019, , 1812.更正：Oh, J.Y.等人，“miR-212-3p在唑来膦酸处理的体外和原位体内模型以及患者来源的骨肉瘤细胞中的协同自噬作用”，2019年，，1812。
Cancers (Basel). 2020 May 26;12(6):1359. doi: 10.3390/cancers12061359.
本文引用的文献
1
Biological Aging Marker p16 in T Cells and Breast Cancer Risk.T细胞中的生物衰老标志物p16与乳腺癌风险
Cancers (Basel). 2020 Oct 26;12(11):3122. doi: 10.3390/cancers12113122.
Zotero 插件